TY - JOUR
T1 - Universal definition and classification of heart failure
T2 - a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association
AU - Bozkurt, Biykem
AU - Coats, Andrew J.S.
AU - Tsutsui, Hiroyuki
AU - Abdelhamid, Ca Magdy
AU - Adamopoulos, Stamatis
AU - Albert, Nancy
AU - Anker, Stefan D.
AU - Atherton, John
AU - Böhm, Michael
AU - Butler, Javed
AU - Drazner, Mark H.
AU - Michael Felker, G.
AU - Filippatos, Gerasimos
AU - Fiuzat, Mona
AU - Fonarow, Gregg C.
AU - Gomez-Mesa, Juan Esteban
AU - Heidenreich, Paul
AU - Imamura, Teruhiko
AU - Jankowska, Ewa A.
AU - Januzzi, James
AU - Khazanie, Prateeti
AU - Kinugawa, Koichiro
AU - Lam, Carolyn S.P.
AU - Matsue, Yuya
AU - Metra, Marco
AU - Ohtani, Tomohito
AU - Francesco Piepoli, Massimo
AU - Ponikowski, Piotr
AU - Rosano, Giuseppe M.C.
AU - Sakata, Yasushi
AU - Seferović, Petar
AU - Starling, Randall C.
AU - Teerlink, John R.
AU - Vardeny, Orly
AU - Yamamoto, Kazuhiro
AU - Yancy, Clyde
AU - Zhang, Jian
AU - Zieroth, Shelley
N1 - Publisher Copyright:
© 2021 European Society of Cardiology and Elsevier, Inc
PY - 2021/3/1
Y1 - 2021/3/1
N2 - In this document, we propose a universal definition of heart failure (HF) as a clinical syndrome with symptoms and/or signs caused by a structural and/or functional cardiac abnormality and corroborated by elevated natriuretic peptide levels and/or objective evidence of pulmonary or systemic congestion. We also propose revised stages of HF as: At risk for HF (Stage A), Pre-HF (Stage B), Symptomatic HF (Stage C) and Advanced HF (Stage D). Finally, we propose a new and revised classification of HF according to left ventricular ejection fraction (LVEF). This includes HF with reduced ejection fraction (HFrEF): symptomatic HF with LVEF ≤40%; HF with mildly reduced ejection fraction (HFmrEF): symptomatic HF with LVEF 41–49%; HF with preserved ejection fraction (HFpEF): symptomatic HF with LVEF ≥50%; and HF with improved ejection fraction (HFimpEF): symptomatic HF with a baseline LVEF ≤40%, a ≥10 point increase from baseline LVEF, and a second measurement of LVEF > 40%.
AB - In this document, we propose a universal definition of heart failure (HF) as a clinical syndrome with symptoms and/or signs caused by a structural and/or functional cardiac abnormality and corroborated by elevated natriuretic peptide levels and/or objective evidence of pulmonary or systemic congestion. We also propose revised stages of HF as: At risk for HF (Stage A), Pre-HF (Stage B), Symptomatic HF (Stage C) and Advanced HF (Stage D). Finally, we propose a new and revised classification of HF according to left ventricular ejection fraction (LVEF). This includes HF with reduced ejection fraction (HFrEF): symptomatic HF with LVEF ≤40%; HF with mildly reduced ejection fraction (HFmrEF): symptomatic HF with LVEF 41–49%; HF with preserved ejection fraction (HFpEF): symptomatic HF with LVEF ≥50%; and HF with improved ejection fraction (HFimpEF): symptomatic HF with a baseline LVEF ≤40%, a ≥10 point increase from baseline LVEF, and a second measurement of LVEF > 40%.
KW - Cardiomyopathy
KW - Definition of heart failure
KW - HFmrEF
KW - HFpEF
KW - HFrEF
KW - Heart failure
KW - Stages of heart failure
UR - http://www.scopus.com/inward/record.url?scp=85102625847&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102625847&partnerID=8YFLogxK
U2 - 10.1002/ejhf.2115
DO - 10.1002/ejhf.2115
M3 - Article
C2 - 33605000
AN - SCOPUS:85102625847
SN - 1388-9842
VL - 23
SP - 352
EP - 380
JO - European Journal of Heart Failure
JF - European Journal of Heart Failure
IS - 3
ER -